adMare Academy BioInnovation Scientist Program Info Session

Target Students: Biology, Biochemistry, Chemistry, Physics, Chemical Engineering

adMare Academy BioInnovation Scientist Program
Are you wondering if you have the essential skills needed to create a successful career in the Canadian bio-economy?

Join us on October 19th, 2022, at 12 PM ET to hear Dr. Edie Dullaghan, Director Learner Engagement of the adMare Academy, introduce the BioInnovation Scientist (BIS) Training Program.  

The unique and substantive BIS Program is designed to support early career scientists in their transition to industry roles, introducing the foundational concepts needed to become commercially minded innovators. This online program was designed to complement students' academic education and employer talent development programs.

Want more information on the BioInnovation Scientist program?
This webinar will give students a glimpse of how they can expand their skillset beyond bench work to obtain a better understanding of what it takes to commercialize and bring to market novel therapeutic products through this program. It is intended for those who already have a BSc. or higher degree, but all students are welcome! Come take advantage of the adMare Academy programs today!
 
About the speaker
As Director, Learner Engagement of the adMare Academy, Dr. Edie Dullaghan plays a direct role in the development and advancement of scientific talent within the Canadian life sciences ecosystem. At adMare, Dr. Dullaghan supports the Academy's programs, including The BioInnovation Scientist Program, a one-of-a-kind program for early-career scientists looking to build a drug development and commercialization career in Canada's life sciences industry.
 
Previously, Dr. Dullaghan worked at CDRD - The Centre for Drug Research and Development as the Director of Target Validation, where she spent over ten years advancing made-in-Canada innovations while also mentoring the next generation of drug developers. Prior to joining CDRD, Dr. Dullaghan served as the Pathogenomics Project Leader for Inimex Pharmaceuticals Inc., developing robust animal models of human infections with a focus toward host defense peptides and small molecules. Over the course of her career, she has managed several large-scale R&D programs, including leading a global collaboration with LifeArc and The Defence Science and Technology Laboratories (DSTL) in the United Kingdom using a novel approach in drug target discovery that capitalises on areas of commonality across pathogens.
 
Dr. Dullaghan obtained her PhD in the U.K. at the National Institute for Medical Research, studying the molecular genetics of the SOS response in Mycobacterium tuberculosis, the causative agent of TB.
 
About adMare BioInnovations
With a wealth of globally-competitive scientific discovery, Canada is primed to lead the life sciences world. To make this a reality, at adMare BioInnovations, we use our scientific and commercial expertise, specialized R&D infrastructure, and seed capital to build strong life sciences companies, robust ecosystems and industry-ready talent - and re-invest our returns back into the Canadian industry to ensure it is sustained for the long-term.

TO REGISTER: https://us02web.zoom.us/meeting/register/tZUlfuugqTooGNCBoL3GAcr2wU3xBgg15ivp